IUPAC/Chemical Name
(1aR,1bS,2R,2aR,5R,6R,7aS,9R,9aR,10aS,11R)-2,6,9,9a-tetrahydroxy-2,6,10,10-tetramethyltetradecahydro-5,7a-methanocyclohepta[6,7]azuleno[1,2-b]oxiren-11-yl 2-hydroxypropanoate
InChi Key
PTPFNNBWQYPEKV-ITNXZKQQSA-N
InChi Code
InChI=1S/C23H36O8/c1-10(24)18(26)31-16-11-6-7-12-21(5,28)15-14-17(30-14)19(2,3)23(15,29)13(25)8-22(12,16)9-20(11,4)27/h10-17,24-25,27-29H,6-9H2,1-5H3/t10?,11-,12+,13-,14-,15+,16-,17-,20-,21-,22+,23-/m1/s1
SMILES Code
[H][C@@]12[C@](O3)([H])[C@]3([H])C(C)([C@@]1(O)[C@H](O)C[C@@]45C[C@]([C@H](CC[C@]5([C@]2(O)C)[H])[C@H]4OC(C(O)C)=O)(O)C)C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
440.53
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Harada N. [Pharmacological studies on the mechanisms of asebotoxin III-induced centrogenic pulmonary hemorrhagic edema in guinea pigs]. Nihon Yakurigaku Zasshi. 1983 Feb;81(2):105-13. Japanese. PubMed PMID: 6406304.
2: Hotta Y, Ando H, Eto R, Takeya K, Haruna M, Ito K, Sakakibara J. [23Na-NMR measurements of the sodium concentration in guinea pig erythrocytes: the effects of cardiac glycoside and asebotoxin III]. Nihon Yakurigaku Zasshi. 1992 Aug;100(2):143-50. Japanese. PubMed PMID: 1330855.
3: Ohizumi Y, Hikino H. The pharmacological nature of asebotoxin III-induced slower phasic contractile response to nerve stimulation in the guinea pig hypogastric nerve-vas deferens. J Pharm Pharmacol. 1980 Mar;32(3):224-5. PubMed PMID: 6103945.
4: Hotta Y, Fujita M, Nakagawa J, Ando H, Takeya K, Ishikawa N, Sakakibara J. Contribution of cytosolic ionic and energetic milieu change to ischemia- and reperfusion-induced injury in guinea pig heart: fluorometry and nuclear magnetic resonance studies. J Cardiovasc Pharmacol. 1998 Jan;31(1):146-56. PubMed PMID: 9456289.
5: Takeya K, Hotta Y, Harada N, Itoh G, Sakakibara J. Asebotoxin-induced centrogenic pulmonary hemorrhage in guinea pigs. Jpn J Pharmacol. 1981 Feb;31(1):137-40. PubMed PMID: 7253338.
